Advertisement

34 Focus on dermatology: Reviewing new approvals and investigational agents
39 Alogliptin: Fourth DPP-4 approved for diabetes
40 Apixaban: Third oral anticoagulant to compete with warfarin
41 Crofelemer: Botanical drug for noninfectious diarrhea
42 Teduglutide: GLP-2 analog for short bowel syndrome
44 Bedaquiline: New product for multidrug-resistant TB
46 Zolpidem: FDA requires lower doses for insomnia drugs
48 MTM profile: Cocohoba serves patients with HIV
52 Collaborative practice agreements: Seven recommendations for CPAs
53 Residencies: Study analyzes patient care at community residency sites
54 Project IMPACT: Mountain States Health Alliance and Dillons Food Stores
56 Professionwide awards: APhA honors contributions to the profession
58 One to One awards: Pharmacists, students provide outstanding care
62 Academy awards: APhA Academies honor achievements
64 On the docket: Pharmacist violates break policies
66 Hub on policy and advocacy: Pharmacy visits; FDA’s compounding framework
70 Provider status: Development of professionwide principles under way
71 Hydrocodone: FDA Advisory Committee recommends rescheduling
72 Congress update: New committee assignments for 2013
3 Bulletin: Pancreatitis with diabetes meds; PPI patterns, income disparities; kids’ safety
6 Today’s perspective: Your input sought
12 Pharmacists in Action: Pursuing provider status; Gans honored; first PSPC learning session
20 Product showcase: New indications, formulations, OTC
22 OTCs today: High-tech online resources for managing diabetes
24 Integrative medicine: Green coffee bean extract
25 Immunization update: Not enough U.S. adults are getting recommended vaccines
30 MTM pearls: Informed consent and duty to warn
32 Technology forum: Health Design Challenge
88 Error alert: Danger in cutting medication patches
HSE 1 Insomnia: Entitlement and employability among future pharmacists: Part 2
HSE 2 Many faces of MTM: Med rec at University of Kansas Hospital
Related Content